We’re proud to announce the successful recertification of our ISO 13485
Quality Management System, with zero non-compliances and a commendation
for our eQMS! Thank you to our entire team for their hard work and dedication
in maintaining such high standards
Cumulus is excited to be a Health Tech Challengers 2024 finalist in the AI Supported Healthcare category! Join us in Barcelona 4-5 Dec for a pitch battle focused on disruptive products that will transform the future of health! #AI #HealthTech #HTC2024
Cumulus is excited to share data from our first-in-class study which were presented at the 2024 #Alzheimers Association International Conference (#AAIC24) on July 27 & 30. Click to learn more: tinyurl.com/2td4r65p #AAIC2024 #endalz #digitalbiomarkers
Cumulus is pleased to announce the presentation of two posters at the 2024 #Alzheimers Association International Conference (#AAIC24) on July 27 & 30 in Philadelphia. #AAIC2024 #endalz #digitalbiomarkers
Learn more: tinyurl.com/4edjxefs
Join Cumulus Co-founder and CSO, Brian Murphy, PhD at the 7th Annual Digital Biomarkers in Clinical Trials Summit hosted by Roche. Brian will be a panelist in the session “Digital Biomarkers in Neuroscience Today”. #digitalbiomarkers #CNS #clinicaltrials
Its World #Schizophrenia Awareness Day 2024. 1/3 of all cases go undiagnosed. We need better tools that provide objective measures to identify patients and help discover next gen treatments #EEG #neuroscience #digitalbiomarkers
tinyurl.com/29twt66a
For #AlzheimersAwarenessMonth, @CumulusNeuro is honored to be sponsoring a webinar on Friday November 10th titled "Leveraging Digital Biomarkers to Generate Real-World Physiological and Behavioral Data in CNS Clinical Studies". #ENDALZ #CNS #neuroscience
Our research collaborator at the #TrinityCollegeDublin is excited to share interim data from our CNS-102 study at the @PsychSocIreland (PSI) Annual Meeting in Cork on Nov 8th from 2-3pm GMT @tcddublin #CNS #ALS #trinitycollege #PrecisionALS #PSIConf23
Subtle changes in cognition are hard to measure in dementia clinical trials. Data presented at #CTAD2023 confirm it is feasible for #Alzheimers patients to use the Cumulus Platform to provide objective, frequent measures of cognitive function in the home.
Cumulus is proud to share that our Co-founder & CSO Brian Murphy was a featured on a panel titled “Engaging Consumers in Brain Health” moderated by Nicolas Pokorny of #Abbvie at #LausanneX on Oct 12th alongside Matt Trevithick of Blank Slate Technologies.
We are delighted to be showcased as one of the 50 companies in @PwC_UK's Life Sciences Future50 report, illustrating the world-class science and innovation being led by the UK. Find out more here: bit.ly/45Eo8NF
#LifeSciences #BioTech #DigitalHealth
Today, we launched the Life Sciences Future50 report, which sets out how the UK can accelerate the growth of one of its most strategic sectors, #LifeSciences, and transform the country into a global leading hub. Find out more bit.ly/45AISpl
#BioTech
PwC UK's Life Sciences Future50 Report
We are delighted to be showcased as one of the 50 companies in @PwC_UK's Life Sciences Future50 report, illustrating the world-class science and innovation being led by the UK. Find out more: bit.ly/45Eo8NF
#LifeSciences #BioTech #DigitalHealth"
Cumulus is pleased to announce acceptance of 3 posters by the #CTAD23 Scientific Committee. Our team is excited to sharing these data with you in Boston 10/25-27. #Alzheimers #endalz #ADresearch #decentralizedclinicaltrials #clinicaltrials #digitalhealth
At #ECNP2023 in Barcelona on Oct 10th, Cumulus shared exciting new data which demonstrated that translational markers of LTP can be collected at home with minimal support using our FDA-cleared dry sensor 16-channel EEG headset. tinyurl.com/4ya99wx9
Cumulus Neuroscience is excited to announce that CSO and Co-Founder Brian Murphy, PhD is a featured panelist at the upcoming Lausanne X Workshop on October 12th. #LausanneX #Alzheimers #EndAlzheimers #CNS
tinyurl.com/mv5t9dd2
It is estimated that at least 1 in 20 children aged 18 and under worldwide are living with #ADHD. We are honored to work alongside our collaborators at @tcddublin and ADMiRE, the HSE’s first specialist service for children and adolescents with ADHD.
Announcing acceptance of our poster “A low-burden visual evoked potential measurement of neuroplasticity: real-world feasibility and data quality from an at-home pilot study”. Excited to share data at #ECNP2023 Oct 10! #CNS
tinyurl.com/4ws8cve8
Cumulus Neuroscience is proud to announce that our CCO Tina Sampath will be a panelist at the upcoming @HBAnet event Digital Health- Empowering the Future of Healthcare hosted by @Genentech on September 27 from 5 – 8 PM PT.




















